Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome.

Saved in:

Bibliographic Details
Title:	Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome.
Authors:	Patkar S; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Uwanogho D; Department of Neuroscience, James Black Centre, King's College London, London, United Kingdom., Modo M; Department of Neuroscience, James Black Centre, King's College London, London, United Kingdom.; Department of Radiology, University of Pittsburgh, Pittsburgh, PA, United States., Tate RJ; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Plevin R; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom., Carswell HVO; Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, United Kingdom.
Source:	Frontiers in cellular neuroscience [Front Cell Neurosci] 2022 Jul 22; Vol. 16, pp. 917181. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477935 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5102 (Print) Linking ISSN: 16625102 NLM ISO Abbreviation: Front Cell Neurosci Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1662-5102
DOI:	10.3389/fncel.2022.917181